From Nasdaq MarketSite: 2025-06-11 20:43:00

Tempest Therapeutics, Inc. (TPST) has secured a registered direct offering deal with an institutional investor for 739,000 shares of common stock at $6.25 per share, aiming to raise approximately $4.6 million. The agreement, facilitated by H.C. Wainwright & Co., is expected to close around June 12, 2025, pending standard conditions. The proceeds will support Tempest’s strategic alternatives process, working capital, and general corporate needs. The offering falls under a shelf registration statement previously approved by the SEC. TPST’s stock closed at $7.47 on Wednesday, dropping 15.88% but rebounding to $7.50 in after-hours trading on the NasdaqCM.



Read more at Nasdaq MarketSite: Tempest Therapeutics Announces $4.6 Mln Registered Direct Offering With Institutional Investor